Form 4: Lemaitre Vascular Director Boosts Stake Through Award Vesting

Sentiment:

Insider Transaction Report


Lemaitre Vascular Director Bridget A. Ross acquired 10 shares of common stock through the vesting of dividend equivalent rights, increasing her beneficial ownership.

Summary

  • Bridget A. Ross, a Director at Lemaitre Vascular Inc. (LMAT), acquired 10 shares of common stock.
  • The shares were acquired on December 12, 2025, at a price of $0 per share.
  • This acquisition resulted from the release of dividend equivalent rights associated with previously granted restricted stock unit and performance stock unit awards.
  • Specifically, 5 shares were released from dividend equivalent rights connected to a restricted stock unit award granted on December 12, 2022.
  • Another 5 shares were released from dividend equivalent rights connected to a performance stock unit award also granted on December 12, 2022.
  • Following these transactions, Ross beneficially owns 3,465 shares of Lemaitre Vascular Inc. common stock.
  • Fractional shares, if any, were settled in cash on each vesting date, resulting in a final balance of zero for the derivative securities.

Sentiment

Score: 6

Explanation: The filing reports a routine insider acquisition of shares through the vesting of equity awards, which generally aligns management interests with shareholders, indicating a slightly positive sentiment.

Positives

  • Director Bridget A. Ross increased her direct beneficial ownership in Lemaitre Vascular Inc. by 10 shares.
  • The acquisition of shares through vesting of awards aligns the director's interests with those of shareholders.
  • The shares were acquired at no direct cost to the director, reflecting a component of her compensation structure.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This routine insider transaction, involving the vesting of equity awards, is a standard practice in executive compensation across various industries and does not inherently reflect broader industry trends or competitive positioning.

Related Party Transactions

  • The acquisition of shares by a director through the vesting of equity awards represents a related party transaction, as it is a form of compensation from the company to an insider.

Stakeholder Impact

  • Shareholders: Minor positive impact as the director's ownership stake increases, potentially signaling confidence in the company's future and aligning management interests with shareholder value.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers: No direct impact on customers is indicated by this filing.
  • Suppliers: No direct impact on suppliers is indicated by this filing.
  • Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

DateDescription
12/12/2022Grant date for the Restricted Stock Unit (RSU) and Performance Stock Unit (PSU) awards from which the dividend equivalent rights originated.
12/12/2025Transaction date for the acquisition of common stock upon the release of dividend equivalent rights.
12/15/2025Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.

Keywords

Lemaitre Vascular, LMAT, insider transaction, Form 4, beneficial ownership, director, stock award, vesting, dividend equivalent rights, restricted stock units, performance stock units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.